Rozerem Articles
Japan’s Takeda gets five new products approved on home market, and partner Amgen reveals strong results with Vectibix
19 April 2010
Takeda withdraws application for ramelteon
6 October 2008
Japan stock market week to June 23, 2008
30 June 2008
Japan stock market week to March 10, 2008
17 March 2008
Sanofi and Actelion will dominate insomnia market by 2016
3 September 2007
Japan stock market week to August 6, 2007
13 August 2007
Takeda submits MAA application for ramelteon
26 March 2007
Consumers Union outrage over DTC ad "targeting children"
19 March 2007
Takeda's sales reach $2.9B for 1st-qtr 2007
14 August 2006
Japan stock market week to June 26, 2006
3 July 2006
Rozerem shows efficacy as transient insomnia drug
26 June 2006
Japan stock market week to June 19, 2006
26 June 2006
Takeda 's income rises 14.4% in 1st 3 fiscal qtrs
20 February 2006
Japan stock market week to Dec 12
19 December 2005
FDA approves Takeda's ACTOplus met
5 September 2005
Japan stock market week to July 25
1 August 2005
Takeda R&D meeting focuses on insomnia treatment Rozeram
1 August 2005
Japan stock market week to July 18
25 July 2005
Japan stock market week to June 10
20 June 2005
Japan stock market week to June 6
13 June 2005
Japan stock market week to May 30
6 June 2005
Takeda's Ramelteon cleared for Insomnia
10 January 2005
CORRECTION: Takeda's ramelteon is not FDA approved
10 January 2005
Tokyo pharma stocks - week to September 27
4 October 2004
Takeda files ramelteon NDA with FDA
4 October 2004
Tokyo pharma stocks - 2 weeks to August 30
6 September 2004
Takeda plans to file for US approval of TAK-375
6 September 2004
Showing 1-32 of 32 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
